US Approves NVDA H200 Chip Sales to 10 Chinese Companies; Jensen Huang in Beijing
The US government approved sales of NVIDIA H200 chips to 10 Chinese companies on May 14, and CEO Jensen Huang appeared in Beijing at a Trump-Xi banquet. NVDA surged 20% in seven days to near $6 trillion market cap on signals that China trade tensions are easing and AI infrastructure demand is widening beyond the US.
RKey facts
- US government approved NVIDIA H200 chip sales to 10 Chinese companies on May 14
- NVIDIA CEO Jensen Huang appeared in Beijing at Trump-Xi state banquet on same day
- NVDA surged 20% in seven days; market cap touched $5.5 trillion, third-highest globally
- Broadcom and semiconductor suppliers rallied on prospect of widened Chinese AI infrastructure demand
- Active equity managers underperforming; top 10 stocks now 38% of S&P 500, concentration at record highs
What's happening
NVIDIA's approval to sell H200 chips to Chinese buyers marks a significant shift in US export policy under the Trump administration. The decision comes as Elon Musk, Jensen Huang, Tim Cook and other mega-cap CEOs were photographed at a state banquet with Trump and Xi Jinping at the Great Hall of the People in Beijing, signaling a warming of US-China tech relations. Huang's physical presence in Beijing, combined with the H200 export approval on the same day, sent a powerful message to markets that restrictions on advanced chip sales to China are loosening. This directly benefits NVIDIA's data center business, which has been constrained by export rules since 2022.
NVIDIA closed at or near record levels on the news, extending a 20% rally over seven days. The company's market cap touched $5.5 trillion, making it one of the three most valuable companies on Earth. The narrative is straightforward for bulls: if China is no longer a blacklisted market for AI chips, NVIDIA's addressable market for inference, training, and enterprise customers expands by hundreds of billions of dollars. Broadcom and other semiconductor suppliers also gained on prospects of expanded Chinese demand for networking, packaging, and peripheral chips needed for large-scale AI deployments.
However, skeptics note that the market may be front-running the deal. Actual export volumes will be modest compared to total NVIDIA revenue, and geopolitical risk remains high; any escalation in Taiwan tensions or trade disputes could reverse the policy overnight. The Trump-Xi banquet was optics-heavy but produced no concrete commitments on tech trade. Additionally, institutional sentiment on mega-cap tech remains cautious; active managers are underperforming as a handful of names (NVDA, MSFT, AAPL, GOOGL, META) drive index returns. Valuation dispersion is at record highs, suggesting mean reversion risk.
What to watch next
- 01Trump-Xi follow-up negotiations on trade and tech; any Taiwan tensions could reverse policy
- 02NVIDIA Q2 earnings guidanceCompany-issued forecasts of future financial performance. on China revenue exposure and H200 demand outlook
- 03Breadth of AI capex: Cisco, Broadcom, and networking plays vs. concentration in mega-cap chips
- PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Angi Inc. - ANGI
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Angi Inc. ("Angi" or the "Company") (NASDAQ: ANGI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns...
43m ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BayCom Corp - BCML
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of BayCom Corp ("BayCom" or the "Company") (NASDAQ: BCML). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation...
43m ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sanara MedTech, Inc. ("Sanara" or the "Company") (NASDAQ: SMTI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
43m ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Forward Air Corporation - FWRD
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Forward Air Corporation ("Forward Air" or the "Company") (NASDAQ: FWRD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
43m ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPL
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Replimune Group, Inc. ("Replimune" or the "Company") (NASDAQ: REPL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
43m ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Veritone, Inc. - VERI
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Veritone, Inc. ("Veritone" or the "Company") (NASDAQ: VERI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation...
43m ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation...
43m ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nano-X Imaging Ltd. - NNOX
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nano-X Imaging Ltd. ("Nano-X" or the "Company") (NASDAQ: NNOX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
43m ago
Related coverage
- NVDA, MSFT, GOOGL Hit ATH as Memory Shortage Sustains Chip RallyTech & AI··0 mentions
- US Approves NVIDIA H200 Sales to 10 Chinese Companies Amid Trump-Xi TalksTech & AI··0 mentions
- NVDA, MSFT, GOOGL Lead S&P 500 as AI Infrastructure Spending Hits New PeakTech & AI··0 mentions
- S&P 500 Breadth Narrows as AI Rally Driven by Handful of Mega-Cap Names; Active Managers StruggleEquities US··0 mentions
More about $NVDA
- Top 10 Stocks Now 38% of S&P 500; Record Concentration Amid Mega-Cap AI Rally Pressures SPY Breadth·Equities US
- Cerebras IPO Raises $5.55B as AI Chipmaker Demand Surges; NVDA H200 Deal Widens Buildout·Tech & AI
- US Approves NVIDIA H200 Sales to 10 Chinese Companies Amid Trump-Xi Talks·Tech & AI
- Cerebras IPO Soars 89% Above Listing; AI Chip Demand Drives $5.55 Billion Raise·Tech & AI
- Cerebras IPO Surges 89% on AI Chipmaker Demand; $5.55B Haul Beats Estimates·Tech & AI
Tracking AI infrastructure capex — hyperscaler spend, data center buildouts, memory demand and the margin compression risk.